Teva Pharmaceutical Industries Limited (NYSE:TEVA) is planning to acquire Celltrion, Inc. (KOSDAQ:A068270), people familiar with the matter said. Reports named AstraZeneca PLC (LSE:AZN) and Roche Holding AG (SWX:ROG) as also holding acquisition talks with Celltrion. Celltrion declined to comment on the reports.